apitegromab tirzepatide A drug called may help to preserve lean body mass during weight loss with tirzepatide, a GLP-1 receptor agonist, according to a phase 2 clinical trial published in Nature Medicine. The Apitegromab muscle loss trial shows
Description
& Keenaghan, M

Physical changes to the medication itself can signal degradation

Internat J Can

Is blindness listed as a side effect of Mounjaro on the patient information leaflet
